Asplundh Cancer Pavilion | Jefferson Health

Clinical research site in Philadelphia, Pennsylvania

As of July 2026, 1 paid clinical trial is recruiting at Asplundh Cancer Pavilion | Jefferson Health in Philadelphia, Pennsylvania. Active studies at this site focus on Low Grade Serous Ovarian Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Asplundh Cancer Pavilion | Jefferson Health (1)

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for Low Grade Serous Ovarian Cancer

38 locations incl. Phoenix

Sponsor: Verastem, Inc.

Sex: Female·Age: 18+

Code: NCT06072781·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

More research sites in Philadelphia

University of Pennsylvania (357 trials)
Children's Hospital of Philadelphia (306 trials)
Thomas Jefferson University Hospital (112 trials)
Thomas Jefferson University (95 trials)
Fox Chase Cancer Center (94 trials)
Hospital of the University of Pennsylvania (87 trials)
The Children's Hospital of Philadelphia (42 trials)
Temple University (39 trials)
Temple University Hospital (38 trials)
University of Pennsylvania/Abramson Cancer Center (30 trials)

Explore more

Paid clinical trials in Philadelphia, PA · Pennsylvania clinical trials